抗中性粒细胞胞质抗体相关性血管炎的大血管受累
该研究通过Mayo Clinic Rochester的医学文本搜索算法,纳入2000年1月1日至2021年12月31日诊断的36例大血管受累的抗中性粒细胞胞质抗体相关性血管炎(L-AAV)患者,描述其临床特征。17例为颞动脉受累,10例为主动脉受累,9例为主动脉周围软组织受累;大多数患者在1年内同时诊断为大血管血管炎和AAV。作者认为AAV可累及大动脉(尽管不常见),对L-AAV患者应考虑针对AAV的治疗。
要点
- 36例L-AAV患者中,17例为颞动脉受累,10例为主动脉受累,9例为主动脉周围软组织受累。
- 25例(69%)患者在1年内同时诊断为大血管血管炎和AAV。
- 25例(69%)患者在颞动脉、主动脉或主动脉周围软组织以外的部位有AAV的组织病理学确诊。
核心结论
- 这是迄今为止最大的单中心L-AAV患者队列。
- AAV可累及大动脉,尽管不常见。
- 对L-AAV患者应考虑针对AAV的治疗(作者结论)。
研究设计与样本
- 研究通过专有医学文本搜索算法,识别2000年1月1日至2021年12月31日在Mayo Clinic Rochester就诊、诊断时年龄大于18岁的颞动脉AAV、主动脉AAV和主动脉周围软组织AAV患者。
- 纳入标准为诊断为L-AAV、符合2022年美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)关于GPA、MPA或EGPA的分类标准、ANCA检测结果阳性、且有超过1次门诊或住院就诊。
- 研究队列共36例L-AAV患者,其中23例为p-ANCA和/或MPO-ANCA阳性,13例为c-ANCA和/或PR3-ANCA阳性。
- AAV诊断时平均(标准差)年龄为63.4(12.79)岁;20例(56%)为男性。
主要发现
- 17例患者为颞动脉AAV,10例为主动脉AAV,9例为主动脉周围软组织AAV。
- 大多数患者(n=25,69%)在大血管血管炎和AAV诊断之间的1年时间内被诊断。
- 25例(69%)患者在颞动脉、主动脉或主动脉周围软组织以外的部位有AAV诊断的组织病理学确认。
- 糖皮质激素(36/36)、利妥昔单抗(19/36)和甲氨蝶呤(18/36)是最常用的治疗。
临床怎么用
- 作者结论提出,对L-AAV患者应考虑针对AAV的治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: ANCA-associated vasculitis (AAV) is currently categorized under the small vessel vasculitides. There is limited knowledge about large vessel involvement in AAV (L-AAV), mainly described in case reports and small series. L-AAV can involve temporal arteries (TA-AAV), aorta (A-AAV), and periaortic soft tissue (PA-AAV). We sought to characterize the features of patients with L-AAV. METHODS: Patients older than 18 years at diagnosis of TA-AAV, A-AAV and PA-AAV seen at the Mayo Clinic, Rochester between 1 January 2000 and 31 December 2021 were identified through a proprietary medical text search algorithm. Patients were included if diagnosed with L-AAV, fulfilled 2022 ACR/EULAR classification criteria for GPA, MPA or EGPA, had positive ANCA test results, and had more than one outpatient or inpatient visit. RESULTS: The study cohort consists of 36 patients with L-AAV. Of those, 23 had p-ANCA and/or MPO-ANCA, and 13 had c-ANCA and/or PR3-ANCA. Mean (s.d.) age at AAV diagnosis was 63.4 (12.79) years; 20 (56%) were male. Seventeen patients had TA-AAV, 10 had A-AAV and 9 had PA-AAV. Most patients (n = 25, 69%) were diagnosed with large vessel vasculitis and AAV within a 1-year timespan. Twenty-five (69%) patients had histopathological confirmation of AAV diagnosis in a location other than temporal artery, aorta or periaortic soft tissue. Glucocorticoids (36/36), rituximab (19/36) and methotrexate (18/36) were the most frequent treatments. CONCLUSION: This is the largest single-centre cohort of patients with L-AAV to date. AAV can involve large arteries, albeit infrequent. AAV-targeted therapy should be considered in patients with L-AAV.
引用
- Kaymakci MS, Elfishawi MM, Langenfeld HE, et al. Large vessel involvement in antineutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford). 2024. PMID: 37672018. doi:10.1093/rheumatology/kead467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。